(Q34644525)

3 August 2017

1 reference

title

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis (English)

1 reference

3 August 2017

Neisseria meningitidis

1 reference

1 reference

1 reference

2

Brian Greenwood

1 reference

3 August 2017

Petter Brandtzaeg

3

0 references

author name string

David S Stephens

series ordinal

1

1 reference

PubMed ID

17604802

3 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

3 August 2017

1 reference

3 August 2017

369

1 reference

3 August 2017

9580

1 reference

3 August 2017

2196-2210

1 reference

3 August 2017

Meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Update on meningococcal disease with emphasis on pathogenesis and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Capsule switching of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Meningococcal genome dynamics.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Site-specific insertion of IS1301 and distribution in Neisseria meningitidis strains

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Epidemiology and pathogenesis of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Genetic Basis for NongroupableNeisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Interactions of pathogenic neisseriae with epithelial cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

The role of porins in neisserial pathogenesis and immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Effect of Neisseria meningitidis fur mutations on global control of gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that r

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Manson Lecture. Meningococcal meningitis in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Mortality from meningococcal disease during an epidemic in The Gambia, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Serogroup C meningococcal outbreaks in the United States. An emerging threat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Invasive meningococcal disease in adolescents and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Serogroup Y meningococcal disease in Chicago, 1991-1997

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Human immunity to the meningococcus. II. Development of natural immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Shift in the age-distribution of meningococcal disease as predictor of an epidemic?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Environmental risk and meningitis epidemics in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Timely detection of meningococcal meningitis epidemics in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Potential of environmental models to predict meningitis epidemics in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Neisseria meningitidis: an overview of the carriage state

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Interaction of Neisseria meningitidis with human nasopharyngeal mucosa: attachment and entry into columnar epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Uncloaking the meningococcus: dynamics of carriage and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

A Simultaneous Outbreak of Meningococcal and Influenza Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Meningococcal disease and season in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Factors affecting carriage of Neisseria meningitidis among Greek military recruits

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Social behavior and meningococcal carriage in British teenagers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Host genetic determinants of Neisseria meningitidis infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Assessment of complement deficiency in patients with meningococcal disease in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Risk and protective factors for meningococcal disease in adolescents: matched cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Sporadic meningococcal disease in adults: results of a 5-year population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Meningitis bacterium is viable without endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Pili and Outer Membrane Appendages on Neisseria meningitidis in the Cerebrospinal Fluid of an Infant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Fatal meningococcal septicaemia with "blebbing" meningococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through toll-like receptor 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Fulminant meningococcal septicemia: dissociation between plasma thrombopoietin levels and platelet counts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Complement activation and endotoxin levels in systemic meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Complement activation in relation to capillary leakage in children with septic shock and purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Nitric oxide production in meningococcal disease is directly related to disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Prognostic indicators of the outcome of meningococcal disease: a study of 562 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Invasive meningococcal infection in Western Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Diagnostic assessment of haemorrhagic rash and fever

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

The child with a non-blanching rash: how likely is meningococcal disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Meningococcal bacterial DNA load at presentation correlates with disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Cytokines, chemokines and other effector molecules involved in meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Chemokine patterns in meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Meningococcal infections at the start of the 21st century.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Chronic meningococcaemia: a forgotten meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Clinical recognition of meningococcal disease in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Parents' and GPs' key role in diagnosis of meningococcal septicaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Molecular methods for the detection and characterization of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

High sensitivity and specificity of the Pastorex® latex agglutination test for Neisseria meningitidis serogroup A during a clinical trial in Niger

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Prospective controlled study of the diagnostic value of skin biopsy in patients with presumed meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Case fatality rates for meningococcal disease in an English population, 1963-98: database study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Emergency management of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Treatment of meningococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

1 reference

7 January 2021

Improving promptness of antibiotic treatment in meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

No increase in endotoxin release during antibiotic killing of meningococci

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Early treatment with parenteral penicillin in meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Effectiveness of antibiotics given before admission in reducing mortality from meningococcal disease: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Serogroups, serotypes, serosubtypes and antimicrobial susceptibility of Neisseria meningitidis isolates in Casablanca, Morocco

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Fatal outcome from meningococcal disease--an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Bacterial meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Community-acquired bacterial meningitis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Adjuvant therapy for meningococcal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Advances in the emergency management of pediatric sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Fluid resuscitation in severe sepsis and septic shock: an evidence-based review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Pediatric considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: A retrospective study*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: evidence of adrenal insufficiency?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J5 study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Features and outcome in meningococcal disease presenting with maculopapular rash

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Plasma and whole blood exchange in meningococcal sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Plasma patterns of tumor necrosis factor-alpha (TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Meningococcal disease prevention and control strategies for practice-based physicians (Addendum: recommendations for college students). Committee on Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Modeling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Meningococcal polysaccharide-protein conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

A universal vaccine for serogroup B meningococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961016-2

7 January 2021

10.1016/S0140-6736(07)61016-2

Identifiers

DOI

1 reference

release_n3zk6oo2engplkdf7agrlehg3q

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n3zk6oo2engplkdf7agrlehg3q

24 November 2022

mapped directly with Wikidata item

PubMed ID

17604802

1 reference

PubMed ID

17604802